150 related articles for article (PubMed ID: 1924141)
1. The relationship of diastereomer hydrolysis kinetics to shelf-life predictions for cefuroxime axetil.
Nguyen NA
Pharm Res; 1991 Jul; 8(7):893-8. PubMed ID: 1924141
[TBL] [Abstract][Full Text] [Related]
2. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution.
Wang D; Notari RE
J Pharm Sci; 1994 Apr; 83(4):577-81. PubMed ID: 8046618
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
[TBL] [Abstract][Full Text] [Related]
4. Photoisomerization kinetics of cefuroxime axetil and related compounds.
Fabre H; Ibork H; Lerner DA
J Pharm Sci; 1994 Apr; 83(4):553-8. PubMed ID: 8046613
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of stability of cefuroxime axetil in solid state.
Zajac M; Jelińska A; Dobrowolski L; Oszczapowicz I
J Pharm Biomed Anal; 2003 Aug; 32(6):1181-7. PubMed ID: 12907262
[TBL] [Abstract][Full Text] [Related]
6. The stability of the amorphous form of cefuroxime axetil in solid state.
Jelińska A; Dudzińska I; Zajac M; Oszczpowicz I
J Pharm Biomed Anal; 2006 Jun; 41(3):1075-81. PubMed ID: 16563687
[TBL] [Abstract][Full Text] [Related]
7. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions.
Zhou M; Notari RE
J Pharm Sci; 1995 May; 84(5):534-8. PubMed ID: 7658340
[TBL] [Abstract][Full Text] [Related]
8. Experimental Determination and Theoretical Calculation of the Eutectic Composition of Cefuroxime Axetil Diastereomers.
Dalal N; Buckner IS; Wildfong PLD
AAPS PharmSciTech; 2017 Oct; 18(7):2570-2578. PubMed ID: 28229357
[TBL] [Abstract][Full Text] [Related]
9. Stability of cefuroxime axetil in suspensions.
Pramar Y; Das Gupta V; Bethea C; Zerai T
J Clin Pharm Ther; 1991 Oct; 16(5):341-4. PubMed ID: 1752913
[TBL] [Abstract][Full Text] [Related]
10. The stability of Cefuroxime axetil in tablets.
Jelińska A; Dudzińska I; Zajac M; Oszczapowicz I; Krzewski W
Acta Pol Pharm; 2005; 62(3):183-7. PubMed ID: 16193810
[TBL] [Abstract][Full Text] [Related]
11. A stability indicating assay method for cefuroxime axetil and its application to analysis of tablets exposed to accelerated stability test conditions.
Ivana I; Ljiljana Z; Mira Z
J Chromatogr A; 2006 Jun; 1119(1-2):209-15. PubMed ID: 16445930
[TBL] [Abstract][Full Text] [Related]
12. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media.
Robson H; Craig DQ; Deutsch D
Int J Pharm; 2000 May; 201(2):211-9. PubMed ID: 10878327
[TBL] [Abstract][Full Text] [Related]
14. The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions.
Jelińska A; Dobrowolski L; Oszczapowicz I
J Pharm Biomed Anal; 2004 Sep; 35(5):1273-7. PubMed ID: 15336372
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
[TBL] [Abstract][Full Text] [Related]
16. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release.
Robson H; Craig DQ; Deutsch D
Int J Pharm; 2000 Feb; 195(1-2):137-45. PubMed ID: 10675691
[TBL] [Abstract][Full Text] [Related]
17. Stability of cefuroxime axetil oral suspension at different temperature storage conditions.
Uzunović A; Vranić E
Bosn J Basic Med Sci; 2008 Feb; 8(1):93-7. PubMed ID: 18318680
[TBL] [Abstract][Full Text] [Related]
18. Esterase activity toward the diastereomers of cefuroxime axetil in the rat and dog.
Mosher GL; McBee J; Shaw DB
Pharm Res; 1992 May; 9(5):687-9. PubMed ID: 1608904
[No Abstract] [Full Text] [Related]
19. STUDIES OF THE CRYSTALLINE FORM OF CEFUROXIME AXETIL: IMPLICATIONS FOR ITS COMPATIBILITY WITH EXCIPIENTS.
Talaczynska A; Mizera M; Szybowicz M; Nowicka AB; Garbacki P; Paczkowska M; Zalewski P; Kozak M; Oszczapowicz I; Jelinska A; Cielecka-Piontek J
Acta Pol Pharm; 2016 Sep; 73(5):1299-1309. PubMed ID: 29638070
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the action features between cefuroxime axetil and bovine serum albumin].
Wu GK; Yan CN; Liu Y
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Sep; 28(9):2139-43. PubMed ID: 19093579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
